フランスの血液検査・フローサイトメトリー市場

◆英語タイトル:New Frontiers in French Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape
◆発行会社/調査会社:Venture Planning Group
◆商品コード:VPHFC8141
◆発行日:2014年5月
◆調査対象地域:フランス
◆ページ数:250
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Local LicenseUSD6,200 ⇒換算¥700,600見積依頼/購入/質問フォーム
Global LicenseUSD13,600 ⇒換算¥1,536,800見積依頼/購入/質問フォーム
DataPackUSD3,900 ⇒換算¥440,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規販売代理店です。同社発行の市場調査資料のご購入、委託調査サービスに関するお問い合わせは弊社までお願い致します。
Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[フランスの血液検査・フローサイトメトリー市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Complete report $6,200.  DataPack (test volumes, sales forecasts, supplier shares) $3,900.

New Frontiers in French Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape” is Venture Planning Group’s new study designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the French hematology and flow cytometry markets during the next five years. 

The report explores business and technological trends in the French market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide.  New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

French Market Overview

- Facilities performing hematology and flow cytometry testing.

- Test volume and sales projections.

Strategic Recommendations

- New product development opportunities
with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Market Segmentation Analysis

- Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.

- Specimen, test and sales forecasts for over 40 procedures by individual test and market segment:
    
     – Hospitals
     – Commercial/Private Laboratories

Sales and Market Share Analysis

- Sales and market shares of major
instrument and reagent suppliers.

Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual),
Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual),
Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Current and Emerging Products

- Analysis of current and emerging hematology and flow cytometry assays.
- Reagent and instrument sales forecasts by market segment.
- Instrument placements and installed base by manufacturer and model.
- Sales and market shares of reagent and instrument suppliers.

[span style="font-family: tahoma; color: black; font-size: 8pt"]Instrumentation Review [/span]

- The study reviews current instrumentation technologies, and compares features[span style="font-family: tahoma"] [/span][span style="font-family: tahoma; color: black; font-size: 8pt"]of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers. [/span]

[span style="font-family: tahoma; color: black; font-size: 8pt"]- The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, [/span][span style="font-family: tahoma; color: black; font-size: 8pt"]Becton Dickinson, [/span][span style="font-family: tahoma; color: black; font-size: 8pt; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: 'times new roman'"]Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, [/span][span style="font-family: tahoma; color: black; font-size: 8pt; mso-bidi-font-size: 12.0pt; mso-bidi-font-family: 'times new roman'"]Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.[/span][span style="font-family: tahoma; color: black; font-size: 8pt"] [/span][span style="font-family: tahoma; color: black; font-size: 8pt"]

[span style="font-family: tahoma; color: black; font-size: 8pt"]Technology Review[/span]

[/span]

- Assessment of current and emerging technologies
and their potential market applications.

- Comprehensive lists of companies developing
or marketing new technologies and products by test.

Competitive Assessments

- Extensive strategic profiles of major suppliers and emerging market entrants.

- The companies analyzed in the report include:

   – Abbott
   – Agilent Technologies
   – Beckman Coulter/Danaher
   – Becton Dickinson
   – Bio-Rad
   – CellaVision
   – Horiba
   – Iris/Danaher[u]
[/u]
   - Nihon Kohden[u]
[/u]
   – Ortho-Clinical Diagnostics
   – Roche
   - Siemens
   - Sysmex
    
Contains 250 pages and 32 tables

*** レポート目次(コンテンツ)***

※目次は下記のURLでご確認ください。

http://www.vpgcorp.com/webfiles/Hematology/TOCLOTNewFrontiersintheFrenchHematologyandFCMarketBusinessChallengesEmergingTechCompetitiveLandscape.pdf



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(VPHFC8141 )"フランスの血液検査・フローサイトメトリー市場" (英文:New Frontiers in French Hematology and Flow Cytometry Markets: Business Challenges, Emerging Technologies, Competitive Landscape)はVenture Planning Group社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。